Target intelligence / Profile preview

Solute carrier family 35 member G3 (SLC35G3)

Target
SLC35G3
Molecular classification
Transporter, Solute carrier family protein, Multi-pass transmembrane protein, Sugar-nucleotide transporter
01

Overview

SLC35G3 is a member of the SLC35 family of nucleotide sugar transporters found predominantly in the testis, localized to the Golgi apparatus of early round spermatids. It is a multi-pass transmembrane protein responsible for transporting UDP-N-acetylglucosamine into the Golgi, enabling the glycosylation of critical sperm membrane proteins, including those involved in acrosome formation and zona pellucida binding. Mouse SLC35G3 knockout models are sterile due to failure in sperm transit and fertilization processes. Human mutations in SLC35G3 diminish its transporter activity and are associated with male infertility risk. SLC35G3 is thus essential for sperm membrane protein glycosylation and male reproductive fitness. Key references for structure, function, and disease role include functional genetic studies in mice, protein biochemical analysis, and human variant association with infertility. No therapeutic agents currently target SLC35G3, but it may serve as a biomarker for specific infertility syndromes related to glycoprotein processing in sperm.

Other names
TMEM21AAMAC1FLJ40154Acyl-malonyl-condensing enzyme 1Transmembrane protein 21AS35G3_HUMAN
02

Biological functions

Nucleotide sugar transport (UDP-GlcNAc transport for glycosylation)Glycoprotein formation in spermSpermatogenesis (specifically early round spermatids)Sperm membrane protein processing required for fertilization
03

Disease associations

Male infertility (deficiency or mutation in SLC35G3 results in disrupted sperm function and sterility)Implicated in defective zona pellucida binding, oocyte fusion, and sperm-egg interaction
04

Safety considerations

No clinical drug safety data, but knockout or dysfunction of SLC35G3 leads to male sterility
05

Biomarkers

SLC35G3 expression or mutation status may serve as a biomarker for specific forms of male infertility (testicular expression; variants F267L and T179HfsTer27 linked to dysfunctional sperm glycosylation and fertility in humans)

Beyond the preview

Go deeper on Solute carrier family 35 member G3 (SLC35G3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 35 member G3 (SLC35G3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call